Nelarabine Injection
Product Images NDC 81927-111

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 81927-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton01)

Packaging label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous injection by Shorla Oncology Inc. The label includes usage instructions, storage conditions, and manufacturing details indicating AqVida GmbH, Dassow, Germany as the manufacturer and Shorla Oncology Inc., Cambridge, MA as the distributor. The label specifies a single-dose vial with Rx only designation.*

FDA Label Image

Carton (Carton02)

Packaging label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous infusion by Shorla Oncology Inc. It shows a carton for 6 single-dose 50 mL vials with discard unused portion instructions. The label includes inactive ingredients, storage instructions, and manufacturer details.*

FDA Label Image

Label (Label01)

Label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) for intravenous infusion. The label states it is a single-dose vial with unused portion to be discarded. It lists inactive ingredients, storage conditions, and notes it is manufactured by AqVida GmbH, Germany, and distributed by Shorla Oncology Inc.*

FDA Label Image

Structure (Structure001)

Chemical structure of nelarabine, showing the molecular arrangement of atoms including nitrogen, oxygen, and carbon with a methoxy group and hydroxyl groups characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.